Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 41

Trial Status

Completed1
Other1

Role Distribution

Principal Investigator2
PI Rate100%

Activity Timeline

Clinical Trials (2)

Targeted Deprescribing in Patients on Hemodialysis
End Stage Renal Disease on Dialysis (Diagnosis)
PrincipalinvestigatorStart date: 2022-10-01
NCT03731169Phase 4Completed
CYP2C19 Genotype-Specific Dosing Plus TDM on Reaching Therapeutic Voriconazole Blood Levels
Aspergillosis InvasiveFungal Infection
PrincipalinvestigatorStart date: 2018-01-10

Research Network

Collaboration Network

1 collaborators·0 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Research Areas & Affiliations

Affiliations

University Health Network, Toronto

Similar Key Opinion Leaders

Publications (0)

No publications found for this investigator.

Clinical Trials (2)

Showing 2 of 2 trials

NCT03733262PrincipalInvestigator

Targeted Deprescribing in Patients on Hemodialysis

End Stage Renal Disease on Dialysis (Diagnosis)
Unknown
NCT03731169Phase 4PrincipalInvestigator

CYP2C19 Genotype-Specific Dosing Plus TDM on Reaching Therapeutic Voriconazole Blood Levels

Aspergillosis InvasiveFungal Infection
Completed

All 2 trials loaded